DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Efficient Tumor Eradication at Ultralow Drug Concentration via Externally Controlled and Boosted Metallic Iron Magnetoplasmonic Nanocapsules
With the aim to locally enhance the efficacy of cancer nanotherapies, here we present metal iron based magnetoplasmonic drug-loaded nanocapsules (MAPSULES), merging powerful external magnetic concentration in the tumor and efficient photothermal actuation to locally boost the drug therapeutic action at ultralow drug concentrations. The MAPSULES are composed of paclitaxel-loaded polylactic-co-glycolic acid (PLGA) nanoparticles partially coated by a nanodome shape iron/silica semishell. The iron semishell has been designed to present a ferromagnetic vortex for incorporating a large quantity of ferromagnetic material while maintaining high colloidal stability. The large iron semishell provides very strong magnetic manipulation via magnetophoretic forces, enabling over 10-fold higher trapping efficiency in microfluidic channels than typical superparamagnetic iron oxide nanoparticles. Moreover, the iron semishell exhibits highly damped plasmonic behavior, yielding intense broadband absorbance in the near-infrared biological windows and photothermal efficiency similar to the best plasmonic nanoheaters. The in vivo therapeutic assays in a mouse xenograft tumor model show a high amplification of the therapeutic effects by combining magnetic concentration and photothermal actuation in the tumor, leading to a complete eradication of the tumors at ultralow nanoparticle and drug concentration (equivalent to only 1 mg/kg PLGA nanoparticles containing 8 μg/kg of paclitaxel, i.e., 100-500-fold lower than the therapeutic window of the free and PLGA encapsulated drug and 13-3000-fold lower than current nanotherapies combining paclitaxel and light actuation). These results highlight the strength of this externally controlled and amplified therapeutic approach, which could be applied to locally boost a wide variety of drugs for different diseases., This work was financially supported by the European Research Council (ERC-StG) under the European union’s horizon 2020 research and innovation program, ERC proof of concept grant (ERC-2022-PoC1). We acknowledge financial support from grants No MAT2016-77391-R, PID2019-106229RB-I00,PID2020-116844RB-C21,PGC2018-095032-B-100, PCIN2016-093 (M-ERA-NET), RTI2018-095495-J-I00, and RYC2019-027449-I funded by MCIN/AEI/10.13039/501100011033. We thank the Ramon Areces foundation through grant CIVP19A5922. The funding from Generalitat de Catalunya through the 2017-SGR-292 project is also acknowledged. ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the SEV-2017-0706 grant funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
Project:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 MAT2016-77391-R
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-106229RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-116844RB-C21
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PGC2018-095032-B-I00
,
AEI RTI2018-095495-J-I00
,
AEI RYC2019-027449-I
,
AEI SEV-2017-0706
DOI: http://hdl.handle.net/10261/336309, https://api.elsevier.com/content/abstract/scopus_id/85143494286
HANDLE: http://hdl.handle.net/10261/336309, https://api.elsevier.com/content/abstract/scopus_id/85143494286